Imunon Inc.

NASDAQ: IMNN · Real-Time Price · USD
6.42
-0.18 (-2.73%)
At close: Aug 15, 2025, 3:59 PM
6.40
-0.31%
Pre-market: Aug 18, 2025, 04:00 AM EDT

Imunon Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a 500K 500K
Cost of Revenue
718.12K n/a n/a n/a
Gross Profit
-718.12K n/a 500K 500K
Operating Income
-19.13M -21.03M -24.92M -21.01M
Interest Income
450.22K 935.28K 502.58K 18.14K
Pretax Income
-18.62M -20.8M -37.47M -22.15M
Net Income
-18.62M -19.51M -35.9M -20.77M
Selling & General & Admin
7.49M 9.74M 13.69M 10.89M
Research & Development
11.64M 11.29M 11.73M 10.62M
Other Expenses
n/a n/a n/a n/a
Operating Expenses
19.13M 21.03M 25.42M 21.51M
Interest Expense
n/a 197.08K 5.03M 569.88K
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
19.13M 21.03M 25.42M 21.51M
Income Tax Expense
n/a n/a -1.57M -1.38M
Shares Outstanding (Basic)
882.29K 693.47K 547.63K 27.74K
Shares Outstanding (Diluted)
882.29K 693.47K 547.63K 27.74K
EPS (Basic)
-21.1 -28.14 -65.55 -748.77
EPS (Diluted)
-21.1 -28.14 -65.55 -748.77
EBITDA
-17.98M -19.88M -31.71M -20.88M
EBIT
-18.7M -20.6M -32.44M -21.58M
Depreciation & Amortization
718.12K 720K 731.63K 702.92K